Shed’s advertised monthly price is not always the amount a patient should expect to pay to begin care. Some compounded plans display a single monthly figure, while brand-name pages separate medication costs from a Shed membership and provider fee. More importantly, the Wegovy and Zepbound pages contain competing prices and membership amounts. For a household planning an ongoing expense, the central question is therefore not simply which headline looks lowest: it is which product, payment recipient, billing interval and renewal terms actually apply.
This documentary review examines Shed’s own pages and terms, alongside federal clinical context, consulted October 19, 2026. Shed documents a substantial telehealth offering: compounded injections, sublingual products, access to brand-name medication, coaching and home delivery. Its terms distinguish the administrative platform from independent clinical providers. The service has useful features, but the available documents do not resolve every first-payment or cancellation question. The most practical way to assess its cost is to follow the money from enrollment through pharmacy fulfillment and renewal.
At a glance
- Compounded semaglutide pricing
- The plan table lists $199 per month for one month, $179 per month for six months and $159 per month for twelve months; it does not establish the collection schedule.Sources: [9]
- Compounded tirzepatide pricing
- The plan table lists $299 per month for one month, $269 per month for six months and $239 per month for twelve months.Sources: [6]
- Brand-name billing conflict
- Wegovy and Zepbound pages show both $99 and $125 Shed fees in different pricing blocks, with medication paid separately under their cash-pay disclosures.
- Automatic renewal
- Medication programs renew automatically; billing can occur every 28 days or monthly, depending on the program.Sources: [8]
- Cancellation deadline
- The terms require cancellation at least 72 hours before the next billing date to avoid the upcoming charge.Sources: [8]
Start with two potential bills, not one headline
Shed’s brand-name disclosures describe a split-payment arrangement: the patient pays Shed for membership and provider services, then pays the dispensing pharmacy for medication. That distinction changes how an advertised starting price should be read. A medicine-only amount is not an all-in program quote. Our guide to separate program and pharmacy bills explains the budgeting issue, but Shed’s own checkout still needs to identify each charge and its recipient before payment.
For Wegovy, one disclosure lists starting prices of $149 per month for the pill and $199 per month for the pen, for new cash-pay patients. It excludes a $99 Shed membership and provider fee. Elsewhere on that same page, a block lists $349–499 for medication plus $125 per month for membership. That block does not specify the period covered by the medication amount. These are materially different descriptions, not interchangeable versions of one clear offer.
Zepbound presents a similar problem. Its detailed cash-pay disclosure starts at $349 per month for new patients, excludes a $99 Shed fee and directs medication payment to the pharmacy. Another block lists $349–499 for medication plus $125 monthly membership. A further opening offer references a lower starting amount. The documents do not establish which offer governs an individual purchase. A written quote should resolve the presentation, first pharmacy charge, Shed fee and subsequent charges together.
| Offering | Advertised price | Important condition |
|---|---|---|
| Compounded semaglutide injection plan | $199 / $179 / $159 per month | One-, six- and twelve-month plans respectively; collection schedule unresolved |
| Compounded tirzepatide injection plan | $299 / $269 / $239 per month | One-, six- and twelve-month plans respectively; lower figures belong to longer plans |
| Sublingual semaglutide drops | Starting at $229 per month | Product-specific block includes medication, supplies, member support and free shipping |
| Sublingual semaglutide lozenges | Starting at $199 per month | Product-specific month-to-month block lists member support and free shipping |
| Foundayo oral orforglipron | Starting at $149 per month | New cash-pay patients; excludes $125 Shed membership/provider fee; pharmacy paid separately |
Compounded plans have clearer tables—but not complete payment schedules
The compounded injection tables are easier to compare than the brand-name blocks. Semaglutide is listed at $199 per month for a one-month plan, $179 for six months and $159 for twelve months. Tirzepatide is $299, $269 and $239 per month for those respective plan lengths. The lower figures therefore should not be presented as unrestricted month-to-month prices. Shed also advertises savings on the longer plans, but those promotional comparisons do not answer when payment is collected.
Neither table, by itself, establishes whether a longer plan is collected upfront, in installments or through another arrangement. Nor does the stated package duration establish the amount shipped at once, a refill schedule or every consequence of early cancellation. Those are separate questions. Before choosing a longer plan, ask for the amount due today and the dates of later charges. A useful comparison starts with the first payment rather than the advertised monthly equivalent.
Shed’s homepage says its GLP-1 plan price stays the same if the provider increases the prescribed dose. That is a meaningful commercial promise, but it is not a complete statement about every renewal circumstance or product change. Ask whether the promise applies to the exact plan selected and what happens if the clinician recommends a different medication or route. The supplied pricing tables do not independently resolve those scenarios.
Product identity matters as much as price
Shed’s needle-free catalog needs particularly careful reading. Its drops page describes member-specific semaglutide formulations and a sublingual option. The product-specific price block starts at $229 per month and explicitly includes medication, supplies, member support and free shipping. The lozenge page describes semaglutide dissolving under the tongue and lists a month-to-month starting price of $199, with support and free shipping. Its absorption description is the provider’s claim, not independent evidence supplied for this review.
Both pages also mix in Wegovy content and lower headline pricing. Those surrounding references should not replace the $229 drops and $199 lozenge product-specific blocks. Likewise, access to Wegovy as an oral pill or weekly pen, as described by Shed, is not the same offering as its sublingual preparations. Zepbound’s dedicated page specifies a vial. A useful quote should name the drug, formulation, route and presentation rather than simply say “GLP-1.”
Foundayo adds another distinct payment structure. Shed identifies it as oral orforglipron and describes it as FDA-approved for chronic weight management; that is a provider statement about the product, not approval of Shed. Pricing starts at $149 per month for new cash-pay patients, excluding a $125 Shed membership and provider fee, with medication paid separately to the pharmacy. The page’s conflicting “same active ingredient” and “same class” language is not a sound basis for treating different products as identical.
Renewal terms can outweigh a low opening price
Shed’s terms say all medication programs are subscriptions that renew automatically. Depending on the program, billing occurs every 28 days or monthly. Those intervals are not identical: a four-week cycle does not consistently land on the same calendar date. The practical task is to obtain the actual next billing date rather than assume that “monthly” marketing describes the contract. Our explanation of monthly and four-week billing provides context for comparing those schedules.
Cancellation must be submitted at least 72 hours before the next billing date to avoid the upcoming charge. Requests made later apply to the following month. The documented self-service route is the patient portal: open “My Treatments,” then select “Manage Subscription.” That is a concrete cancellation path, but cancellation should not be confused with a refund for money already collected. Keeping confirmation and checking the next scheduled charge are sensible administrative precautions.
A further complication is the refund policy’s reference to a two-month minimum commitment. The supplied excerpt does not clearly establish which plans it covers, and part of the terms was unavailable in the provided material. That unresolved scope matters especially beside month-to-month marketing. Ask Shed to identify the applicable commitment in writing, including whether a longer discounted plan has additional obligations. Neither a plan’s name nor a promotional monthly amount settles that contractual question.
Approval, participation and refunds are separate events
Under the terms, membership fees become nonrefundable once a patient is approved for treatment. If a licensed provider does not approve treatment, the membership fee is refunded. That distinction is useful, but it does not establish a universal medication-refund policy or a timetable for money to reach a bank account. Before paying, clarify what is collected before review and how any separate pharmacy payment is handled if the requested treatment is not prescribed.
Participation requirements also affect the financial outcome. If medication is not shipped because the patient fails to complete required actions, such as a refill request or necessary visit, the terms say that month remains ineligible for a refund. Shed may, at its discretion, offer a one-time credit toward a future shipment after the requirements are completed, provided the subscription remains active. A credit is not cash back, and the possibility of one is not a promise.
The advertised Shed Guarantee is conditional on eligibility, required check-ins and adherence to the treatment plan. The supplied documents do not establish the complete procedure, exclusions or refund calculation for the advertised 120-day guarantee. It should therefore not be treated as unconditional protection against an unsatisfactory purchase. For the broader distinction, see what cancellation does—and does not—mean for refunds. For Shed specifically, request the full applicable guarantee before relying on it.
What membership buys—and who actually provides care
Although the homepage calls Shed a telehealth clinic, the terms identify Shed Holdings, LLC as the site’s owner and an administrative communications platform, not a medical group. Independent professional entities and their affiliated licensed clinicians provide evaluations, prescriptions, treatment plans and follow-up schedules. The supplied material does not identify those groups by legal name or independently verify individual licenses. This division matters when asking who can answer a clinical question versus who can fix an account charge.
Enrollment begins with an advertised five-minute health-history and administration-preference form. A live virtual visit may still be required depending on the state and treatment; an online assessment is not a universal substitute. The terms require patients to be at least 18 and in a state where services are available. Shed advertises telehealth in all 50 states, but particular providers, medications and visit formats depend on where the patient is physically located during the visit.
Support is a genuine part of the advertised offering, though its descriptions vary by program. The tirzepatide page lists coaching, unlimited provider follow-ups, health courses and free Pivot tracking-app access. The homepage adds a dedicated coach and dietitian. Terms for certain memberships describe one 15-minute virtual coaching appointment monthly. Free text coaching may include AI-generated responses that Shed says a licensed coach monitors and reviews. These are different services; ask which are included in the selected membership.
Pharmacy fulfillment is another part of the purchase
Shed includes standard shipping at no additional charge, according to its homepage. Its terms list Strive Compounding Pharmacy, Promise Pharmacy, DCA Pharmacy, Everwell Pharmacy, Custom Ivy Pharmacy and Boothwyn Pharmacy as partners. That list does not tell an individual patient which pharmacy will fill a prescription, and dispensing should not automatically be described as compounding. The terms also permit transfers between partner pharmacies, making the actual dispensing location an important detail to confirm.
The logistics language is broader than a simple domestic-pharmacy description. Shed does not guarantee a product’s place of origin and says products may ship from the United Kingdom, Canada or other locations. The reviewed material supplies no general GLP-1 delivery deadline. A seven-to-ten-business-day estimate appears for women’s hair treatments after provider approval; it should not be imported into a weight-management purchase. Free shipping establishes neither free treatment nor a guaranteed arrival date.
For injectable deliveries, FDA advises not using a GLP-1 product that arrives warm or with insufficient refrigeration and contacting the provider or dispensing pharmacy. That makes an accessible fulfillment contact more than an administrative convenience. Shed’s portal offers messages for account and order support, connections to the medical provider, nursing support and coaching. The documents do not establish a general response-time promise, so ask how urgent delivery concerns are routed before an order is sent.
Judge the budget without mistaking price for evidence
Shed says insurance is not required and describes programs designed to operate without going through insurance. It also says eligible HSA or FSA cards can pay for qualifying services and treatments. That does not determine whether a particular expense qualifies under an individual plan, nor establish insurer coverage, prior authorization or copays. The brand-name prices discussed here are specifically cash-pay offers for new patients. They should not be presented as confirmed insured costs or universal renewal prices.
The provider also discloses that compounded medications are not FDA-reviewed or approved for safety, effectiveness or quality. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and state-licensed pharmacy. Nonapproval alone does not prove clinical inequivalence. However, references to trials of approved injected medicines do not establish outcomes for Shed’s compounded products or different routes. A lower price does not answer that evidence question, and a higher one does not prove better care.
Questions & answers
Is Shed’s lowest compounded price available month to month?
Not according to the published tables. The $159 semaglutide and $239 tirzepatide monthly figures belong to twelve-month plans. The respective one-month figures are $199 and $299. The tables do not establish how longer plans are collected or supplied. Ask for the payment schedule and early-exit terms rather than assuming the monthly equivalent is a cancel-anytime installment.
What does Shed charge for Wegovy or Zepbound membership?
The reviewed pages do not provide one consistent answer. Both show a $99 Shed membership and provider fee in cash-pay disclosures and $125 monthly membership in other blocks. Medication prices also vary across those blocks. Obtain a product-specific written quote that identifies the applicable Shed fee, pharmacy payment, first charge and renewal amount before authorizing payment.
Can I cancel Shed through the portal?
Yes. The terms direct patients to “My Treatments” and then “Manage Subscription” in the patient portal. Cancellation must occur at least 72 hours before the next billing date to avoid the upcoming charge. Later requests apply to the following month. That cancellation mechanism does not itself establish a refund or resolve the policy’s unclear reference to a two-month minimum commitment.
Does Shed guarantee a prescription after the online form?
No guaranteed prescription is documented. Independent clinicians determine treatment suitability, and some patients need a live virtual consultation depending on their state and treatment. The terms say the membership fee is refunded if a licensed provider does not approve treatment. That is distinct from promising approval for the particular medication a patient initially requests.
Does free shipping mean my GLP-1 order arrives within ten business days?
No. Shed documents included standard shipping but no general GLP-1 arrival deadline in this material. The seven-to-ten-business-day estimate concerns women’s hair medication after approval, not all prescriptions. Ask for the expected approval, pharmacy processing and delivery stages for your order, along with the contact route for a delayed or temperature-compromised package.
How do I contact the right Shed support team?
The member portal is the documented central access point. It connects patients with their medical provider, nursing team, health coach, treatment resources and account or order support. Direct clinical concerns to the care team and payment or shipment questions to the appropriate support channel. The supplied material does not establish response-time guarantees or documented Spanish-language service.
Our assessment
Shed documents a broad medication catalog, included standard shipping, several support channels and comparatively readable compounded-plan tables. Its cost transparency is weaker where it matters most for brand-name purchases: conflicting membership fees and medication blocks prevent a reliable all-in estimate from the pages alone. Longer-plan collection schedules, minimum-commitment scope and guarantee details also remain unresolved. The balanced conclusion is not that every Shed offer is unclear, but that the clearest advertised figure is still not a complete contract. Before enrolling, obtain one written statement covering the exact product, amount due now, separate pharmacy charges, renewal date, included support and cancellation obligations.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- Wilding et al. (2021): STEP 1 semaglutide trial ↗
- Jastreboff et al. (2022): SURMOUNT-1 tirzepatide trial ↗
- Shed — products/product/glp 1 lozenges ↗
- Shed — official website ↗
- Shed — products/compounded tirzepatide injections ↗
- Shed — products/product/zepbound shed membership ↗
- Shed — resources/legal/terms ↗
- Shed — products/compounded semaglutide injections ↗
- Shed — products/foundayo ↗
- Shed — products/product/wegovy ↗
- Shed — products/womens hair solutions ↗
- Shed — products/product/glp 1 liquid drops ↗